Aetna
Aetna Aetna
Specialty Pharmacy Clinical Policy Bulletins
Aetna Non-Medicare Prescription Drug Plan
Subject: Specialty Quantity Limit Xpovio 3120-H P2022

Drug
XPOVIO  (selinexor)


Policy:

      I.  PROGRAM DESCRIPTION

          The standard limit is designed to allow a quantity sufficient for
          the most common uses of the medication. The recommended
          dosing parameters for all FDA-approved indications fall within
          the standard limits. Coverage of an additional quantity may be
          reviewed on a case-by-case basis upon request.

 

    II.  COVERED QUANTITIES

      Medication

           Standard Limit

   FDA-recommended dosing

  Xpovio (selinexor)
  80 mg
  twice weekly carton

  1 carton per 28 days
  (thirty-two 20 mg tablets
  per 28 days)

  Multiple myeloma (in combination
  with bortezomib and
  dexamethasone):
100 mg once
  weekly on day 1

  Dose adjustments due to adverse
  reactions
    •    First reduction: 80 mg once
         weekly
    •    Second reduction: 60 mg once
         weekly
    •    Third reduction: 40 mg once
          weekly

 

  Multiple myeloma (in combination
  with dexamethasone):
80 mg twice
  weekly on days 1 and 3

  Dose adjustments due to adverse
  reactions
    •    First reduction: 100 mg once
         weekly
    •    Second reduction: 80 mg once
         weekly
    •    Third reduction: 60 mg once
         weekly

 

  Diffuse large B-cell lymphoma:
  60 mg twice weekly on days 1 and 3

  Dose adjustments due to adverse
  reactions
    •    First reduction: 40 mg twice
         weekly
    •    Second reduction: 60 mg once
         weekly
    •    Third reduction: 40 mg once
         weekly

  Xpovio (selinexor)
  60 mg
  twice weekly carton

  1 carton per 28 days
  (twenty-four 20 mg tablets
  per 28 days)

  Xpovio (selinexor)
  40 mg
  twice weekly carton

  1 carton per 28 days
  (sixteen 20 mg tablets
  per 28 days)

  Xpovio (selinexor)
  40 mg
  twice weekly carton

  1 carton per 28 days
  (eight 40 mg tablets
  per 28 days)

  Xpovio (selinexor)
  100 mg
  once weekly carton

  1 carton per 28 days
  (twenty 20 mg tablets
  per 28 days)

Xpovio (selinexor) 100 mg once weekly carton

  1 carton per 28 days
  (eight 50 mg tablets
  per 28 days)

  Xpovio (selinexor)
  80 mg
  once weekly carton

  1 carton per 28 days (sixteen
  20 mg tablets per 28 days)

  Xpovio (selinexor)
  80 mg
  once weekly carton

  1 carton per 28 days
  (eight 40 mg tablets
  per 28 days)

  Xpovio (selinexor)
  60 mg
  once weekly carton

  1 carton per 28 days
  (twelve 20 mg tablets
  per 28 days)

  Xpovio (selinexor)
  60 mg
  once weekly carton

  1 carton per 28 days
  (four 60 mg tablets
  per 28 days)

  Xpovio (selinexor)
  40 mg
  once weekly carton

  1 carton per 28 days
  (eight 20 mg tablets
  per 28 days)

  Xpovio (selinexor)
  40 mg
  once weekly carton

  1 carton per 28 days
  (four 40 mg tablets
  per 28 days)

 


Place of Service:

Outpatient

The above policy is based on the following references:
  1. Xpovio [package insert]. Newton, MA: Karyopharm Therapeutics Inc.; July 2022.
Copyright Aetna Inc. All rights reserved. Pharmacy Clinical Policy Bulletins are developed by Aetna to assist in administering plan benefits and constitute neither offers of coverage nor medical advice. This Clinical Policy Bulletin contains only a partial, general description of plan or program benefits and does not constitute a contract. Aetna does not provide health care services and, therefore, cannot guarantee any results or outcomes. Participating providers are independent contractors in private practice and are neither employees nor agents of Aetna or its affiliates. Treating providers are solely responsible for medical advice and treatment of members. This Clinical Policy Bulletin may be updated and therefore is subject to change.

April 15, 2023
Aetna
Skip Past Footer Links
Company Information   |   Site Map Aetna.com Home   |   Help   |   Contact Us   |   Search
Web Privacy Statement   |   Legal Statement   |   Privacy Notices   |   Member Disclosure

Back to top